ENO2 and stroke disorder: While some established biomarkers (such as NSE, S100B, and CRP) are used in evaluating both the diagnosis and prognosis of stroke, they also represent very limited aspects of the overall cascade of events associated with stroke and typically are not interpreted either longitudinally or mechanistically [3].